Targeted therapies for high-risk leukemia in children have yet to be ... in Immunology and Cancer are working on a large-scale drug discovery project to get there. In the laboratory run by Brian ...

(“Handa”) (6620.TWO) announced that its U.S. subsidiary, Handa Therapeutics, LLC (the “Company”), has acquired PHYRAGO™ (dasatinib) tablets, a U.S. Food and Drug Administration (“FDA”) approved ...

a U.S. Food and Drug Administration ("FDA") approved chronic myeloid leukemia treatment that was developed by Nanocopoeia, LLC. PHYRAGO is the first and only dasatinib product that can be co ...

a U.S. Food and Drug Administration ("FDA") approved chronic myeloid leukemia treatment that was developed by Nanocopoeia, LLC. PHYRAGO™ is the first and only dasatinib product that can be co ...

PHYRAGO™ Represents the First and Only Improved Version of SPRYCEL ® That Can Be Safely Co-administered With Gastric Acid-Reducing Agents PHYRAGO™ was granted Orphan-Drug Designation and has ...

For decades, mental health treatment has often followed a linear path: Try one intervention, wait to see if it works, and then try another if it doesn't. This sequential approach can leave ...

Institute of Environmental Processes and Pollution Control, School of Environment and Ecology, Jiangnan University, Wuxi 214122, China ...

Authorities in Brazil launched an investigation after three women died and several others were hospitalized after a family ate an arsenic-laced Christmas cake, police told local media. The three ...